Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 May;57(5):1320–1329. doi: 10.1172/JCI108400

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.

R Rebar, H L Judd, S S Yen, J Rakoff, G Vandenberg, F Naftolin
PMCID: PMC436785  PMID: 770505

Abstract

To evaluate gonadotropin release in polycystic ovary syndrome (PCO), one or more of the following hypothalamic-pituitary function tests were performed on 24 patients with the syndrome. These tests included (a) the pulsatile pattern and day-to-day fluctuation of gonadotropin release; (b) effects of exogenous estrogen and antiestrogen (clomiphene) administration on gonadotropin release; and (c) pituitary responsiveness to maximal (150 mug) and submaximal (10 mug) luteinizing hormone-releasing factor (LRF) injections. In 10 of the 14 patients sampled frequently (15 min) for 6 h, luteinizing hormone (LH) levels were elevated above the concentration seen in normal cycling women (except the LH surge). These high LH concentrations appeared to be maintained by and temporally related to the presence of exaggerated pulsatile LH release, either in the form of enhanced amplitude or increased frequency. In all subjects, levels of follicle-stimulating hormone (FSH) were low or low normal, and a pulsatile pattern was not discernible. In four patients, daily sampling revealed marked day-to-day fluctuation of LH but not FSH. That the elevated LH levels were not related to a defect in the negative-feedback effect of estrogen was suggested by the appropriate fall of LH in four patients given an acute intravenous infusion of 17beta-estradiol. This infusion had no effect on FSH levels. In addition, clomiphene elicited rises of both LH and FSH that were comparable to the ones observed in normal women given the same treatment. The clomiphene study also suggested that the positive-feed-back mechanism of estrogen on LH release was intact when the preovulatory rises of 17beta-estradiol induced appropriate LH surges. The elevated LH levels appeared to be related to a heightened pituitary responsiveness to the LRF. This was found in the 11 and 2 patients given maximal (150 mug) and submaximal (10 mug) doses of LRF, respectively. The augmented pituitary sensitivity for LH release correlated with the basal levels of both estrone (P less than 0.025) and 17beta-estradiol (P less than 0.02). The net increase in FSH was significantly greater (P less than 0.001) in the PCO patients than the normal women with maximal doses of LRF. With the smaller dose study none of the injections had a discernible effect on FSH concentrations in either subject. The disparity between LH and FSH secretion could be explained by the preferential inhibitory action of estrogen on FSH release, coupled with a relative insensitivity of FSH release. These data indicate that in these PCO patients the abnormalities of the hypothalamic-pituitary regulation of gonadotropin secretion was not an inherent defect but represented a functional derangement consequent to inappropriate estrogen feedback, which led to a vicious cycle of chronic anovulation and inappropriate gonadotropin secretion.

Full text

PDF
1320

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELROD L. R., GOLDZIEHER J. W. The polycystic ovary. III. Steroid biosynthesis in normal and polycystic ovarian tissue. J Clin Endocrinol Metab. 1962 Apr;22:431–440. doi: 10.1210/jcem-22-4-431. [DOI] [PubMed] [Google Scholar]
  2. Axelrod L. R., Goldzieher J. W. The polycystic ovary. V. Alternate pathways of steroid aromatization in normal, pregnancy and polycystic ovaries. J Clin Endocrinol Metab. 1965 Sep;25(9):1275–1278. doi: 10.1210/jcem-25-9-1275. [DOI] [PubMed] [Google Scholar]
  3. Bardin C. W., Lipsett M. B. Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest. 1967 May;46(5):891–902. doi: 10.1172/JCI105588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berger M. J., Taymor M. L., Patton W. C. Gonadotropin levels and secretory patterns in patients with typical and atypical polycystic ovarian disease. Fertil Steril. 1975 Jul;26(7):619–626. [PubMed] [Google Scholar]
  5. DeVane G. W., Czekala N. M., Judd H. L., Yen S. S. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol. 1975 Feb 15;121(4):496–500. doi: 10.1016/0002-9378(75)90081-2. [DOI] [PubMed] [Google Scholar]
  6. GALLAGHER T. F., KAPPAS A., HELLMAN L., LIPSETT M. B., PEARSON O. H., WEST C. D. Adrenocortical hyperfunction in idiopathic hirsutism and the Stein-Leventhal syndrome. J Clin Invest. 1958 Jun;37(6):794–799. doi: 10.1172/JCI103666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GOLDZIEHER J. W., AXELROD L. R. The polycystic ovary. II. Urinary steroid excretion. J Clin Endocrinol Metab. 1962 Apr;22:425–430. doi: 10.1210/jcem-22-4-425. [DOI] [PubMed] [Google Scholar]
  8. GOLDZIEHER J. W., GREEN J. A. The polycystic ovary. I. Clinical and histologic features. J Clin Endocrinol Metab. 1962 Mar;22:325–338. doi: 10.1210/jcem-22-3-325. [DOI] [PubMed] [Google Scholar]
  9. Gambrell R. D., Jr, Greenblatt R. B., Mahesh V. B. Inappropriate secretion of LH in the Stein-Leventhal syndrome. Obstet Gynecol. 1973 Sep;42(3):429–440. [PubMed] [Google Scholar]
  10. Jaffe R. B., Keye W. R., Jr Estradiol augmentation of pituitary responsiveness to gonadotropin-releasing hormone in women. J Clin Endocrinol Metab. 1974 Nov;39(5):850–855. doi: 10.1210/jcem-39-5-850. [DOI] [PubMed] [Google Scholar]
  11. KASE N., KOWAL J., PERLOFF W., SOFFER L. J. IN VITRO PRODUCTION OF ANDROGENS BY A VIRILIZING ADRENAL ADENOMA AND ASSOCIATED POLYCYSTIC OVARIES. Acta Endocrinol (Copenh) 1963 Sep;44:15–19. doi: 10.1530/acta.0.0440015. [DOI] [PubMed] [Google Scholar]
  12. KEETTEL W. C., BRADBURY J. T., STODDARD F. J. Observations on the polycystic ovary syndrome. Am J Obstet Gynecol. 1957 May;73(5):954-62; discussion, 962-5. [PubMed] [Google Scholar]
  13. LEVENTHAL M. L., SCOMMEGNA A. MULTIGLANDULAR ASPECTS OF THE STEIN-LEVENTHAL SYNDROME. Am J Obstet Gynecol. 1963 Oct 15;87:445–454. doi: 10.1016/0002-9378(63)90552-0. [DOI] [PubMed] [Google Scholar]
  14. Lasley B. L., Wang C. F., Yen S. S. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs. J Clin Endocrinol Metab. 1975 Nov;41(5):820–826. doi: 10.1210/jcem-41-5-820. [DOI] [PubMed] [Google Scholar]
  15. MAHESH V. B., GREENBLATT R. B. Isolation of dehydroepiandrosterone and 17alpha-hydroxy-delta5-pregenolone from the polycystic ovaries of the Stein-Leventhal syndrome. J Clin Endocrinol Metab. 1962 Apr;22:441–448. doi: 10.1210/jcem-22-4-441. [DOI] [PubMed] [Google Scholar]
  16. MAHESH V. B., GREENBLATT R. B. Physiology and pathogenesis of the Stein-Leventhal syndrome. Nature. 1961 Aug 26;191:888–890. doi: 10.1038/191888a0. [DOI] [PubMed] [Google Scholar]
  17. MAHESH V. B., GREENBLATT R. B. STEROID SECRETIONS OF THE NORMAL AND POLYCYSTIC OVARY. Recent Prog Horm Res. 1964;20:341–394. [PubMed] [Google Scholar]
  18. McARTHUR J. W., INGERSOLL F. M., WORCESTER J. The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system. J Clin Endocrinol Metab. 1958 Nov;18(11):1202–1215. doi: 10.1210/jcem-18-11-1202. [DOI] [PubMed] [Google Scholar]
  19. Midgley A. R., Jr, Jaffe R. B. Regulation of human gonadotropins. X. Episodic fluctuation of LH during the menstrual cycle. J Clin Endocrinol Metab. 1971 Dec;33(6):962–969. doi: 10.1210/jcem-33-6-962. [DOI] [PubMed] [Google Scholar]
  20. Patton W. C., Berger M. J., Thompson I. E., Chong A. P., Grimes E. M., Taymor M. L. Pituitary gonadotropin responses to synthetic luteinizing hormone-releasing hormone in patients with typical and atypical polycystic ovary disease. Am J Obstet Gynecol. 1975 Feb 1;121(3):382–386. doi: 10.1016/0002-9378(75)90017-4. [DOI] [PubMed] [Google Scholar]
  21. Rebar R., Yen S. S., VandenBerg G., Naftolin F., Ehara Y., Engblom S., Ryan K. J., Amoss M., Guillemin R. Gonadotropin responses to synthetic LRF: dose-response relationship in men. J Clin Endocrinol Metab. 1973 Jan;36(1):10–16. doi: 10.1210/jcem-36-1-10. [DOI] [PubMed] [Google Scholar]
  22. Santen R. J., Bardin C. W. Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms. J Clin Invest. 1973 Oct;52(10):2617–2628. doi: 10.1172/JCI107454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tsai C. C., Yen S. S. Acute effects of intravenous infusion of 17-beta-estradiol on gonadotropin release in pre- and post-menopausal women. J Clin Endocrinol Metab. 1971 Jun;32(6):766–771. doi: 10.1210/jcem-32-6-766. [DOI] [PubMed] [Google Scholar]
  24. Vandenberg G., DeVane G., Yen S. S. Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor. J Clin Invest. 1974 Jun;53(6):1750–1754. doi: 10.1172/JCI107727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Vandenberg G., Yen S. S. Effect of anti-estrogenic action of clomiphene during the menstrual cycle: evidence for a change in the feedback sensitivity. J Clin Endocrinol Metab. 1973 Sep;37(3):356–365. doi: 10.1210/jcem-37-3-356. [DOI] [PubMed] [Google Scholar]
  26. WARREN J. C., SALHANICK H. A. Steroid biosynthesis in the human ovary. J Clin Endocrinol Metab. 1961 Oct;21:1218–1230. doi: 10.1210/jcem-21-10-1218. [DOI] [PubMed] [Google Scholar]
  27. Wang C. F., Yen S. S. Direct evidence of estrogen modulation of pituitary sensitivity to luteinizing hormone-releasing factor during the menstrual cycle. J Clin Invest. 1975 Jan;55(1):201–204. doi: 10.1172/JCI107913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yen S. C., Llerena L. A., Pearson O. H., Littell A. S. Disappearance rates of endogenous follicle-stimulating hormone in serum following surgical hypophysectomy in man. J Clin Endocrinol Metab. 1970 Mar;30(3):325–329. doi: 10.1210/jcem-30-3-325. [DOI] [PubMed] [Google Scholar]
  29. Yen S. S. Gonadotropin-releasing hormone. Annu Rev Med. 1975;26:403–417. doi: 10.1146/annurev.me.26.020175.002155. [DOI] [PubMed] [Google Scholar]
  30. Yen S. S., Lasley B. L., Wang C. F., Leblanc H., Siler T. M. The operating characteristics of the hypothalamic-pituitary system during the menstrual cycle and observations of biological action of somatostatin. Recent Prog Horm Res. 1975;31:321–363. doi: 10.1016/b978-0-12-571131-9.50013-x. [DOI] [PubMed] [Google Scholar]
  31. Yen S. S., Llerena O., Little B., Pearson O. H. Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. J Clin Endocrinol Metab. 1968 Dec;28(12):1763–1767. doi: 10.1210/jcem-28-12-1763. [DOI] [PubMed] [Google Scholar]
  32. Yen S. S., Tsai C. C., Naftolin F., Vandenberg G., Ajabor L. Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J Clin Endocrinol Metab. 1972 Apr;34(4):671–675. doi: 10.1210/jcem-34-4-671. [DOI] [PubMed] [Google Scholar]
  33. Yen S. S., Tsai C. C. The effect of ovariectomy on gonadotropin release. J Clin Invest. 1971 May;50(5):1149–1153. doi: 10.1172/JCI106587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Yen S. S., Tsai C. C., Vandenberg G., Rebar R. Gonadotropin dynamics in patients with gonadal dysgenesis: a model for the study of gonadotropin regulation. J Clin Endocrinol Metab. 1972 Dec;35(6):897–904. doi: 10.1210/jcem-35-6-897. [DOI] [PubMed] [Google Scholar]
  35. Yen S. S., VandenBerg G., Rebar R., Ehara Y. Variation of pituitary responsiveness to synthetic LRF during different phases of the menstrual cycle. J Clin Endocrinol Metab. 1972 Dec;35(6):931–934. doi: 10.1210/jcem-35-6-931. [DOI] [PubMed] [Google Scholar]
  36. Yen S. S., Vandenberg G., Siler T. M. Modulation of pituitary responsiveness to LRF by estrogen. J Clin Endocrinol Metab. 1974 Jul;39(1):170–177. doi: 10.1210/jcem-39-1-170. [DOI] [PubMed] [Google Scholar]
  37. Yen S. S., Vela P., Rankin J. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab. 1970 Apr;30(4):435–442. doi: 10.1210/jcem-30-4-435. [DOI] [PubMed] [Google Scholar]
  38. Yen S. S., Vela P., Ryan K. J. Effect of clomiphene citrate in polycystic ovary syndrome: Relationship between serum gonadotropin and corpus luteum function. J Clin Endocrinol Metab. 1970 Jul;31(1):7–13. doi: 10.1210/jcem-31-1-7. [DOI] [PubMed] [Google Scholar]
  39. Zárate A., Canales E. S., De la Cruz A., Soria J., Schally A. V. Pituitary response to synthetic LH-RH in Stein-Leventhal syndrome and functional amenorrhea. Obstet Gynecol. 1973 Jun;41(6):803–808. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES